SXC 2023 [1695562-36-7]

TargetMol Chemicals

SXC 2023 [1695562-36-7]

9

Chemical

Research Use Only

SXC 2023

99.65%

C13H15NO4S

281.33

SXC 2023 ((S)-2-acetamido-3-(4-methylbenzoylthio)propanoic acid) is a therapeutic prodrug of N-acetyl-L-cysteine for the treatment of CNS disorders and neurocognitive disorders, and can be used to treat glutamatergic dysfunction and psychiatric disorders in which oxidative stress plays a key role.

3 years

C(SC[C@H](NC(C)=O)C(O)=O)(=O)C1=CC=C(C)C=C1

-20°C

12352200